Evidence map›Paper›PMID 41387170›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Adenylyl Cyclase 8 in Dorsal CA1 Neurons Prevents Depressive-Like Behaviors by Maintaining Neuronal Excitability and Glutamatergic Neurotransmission Through TIP39-PTH2R Signaling.

Zi-Jie Liu, Jia-Rui Bi, Zong-Yan Yu, Meng Tian, Zhi-Yue Chen, Ran Wei, Miao-Miao Wang, Hai-Wei Zha, Yu-Qing Zhang, Hong-Jing Wang and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zi-Jie LiuNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Jia-Rui BiNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Zong-Yan YuThe Affiliated TCM Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Meng TianKey Laboratory of Molecular Epigenetics, Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.
Zhi-Yue ChenNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Ran WeiNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Miao-Miao WangNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Hai-Wei ZhaNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Yu-Qing ZhangNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Hong-Jing WangThe Affiliated TCM Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Bang-You QiangThe Affiliated TCM Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Shuang-Shuang SunThe Affiliated TCM Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Xiao-Juan ZhuKey Laboratory of Molecular Epigenetics, Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.
Wen-Bing ChenThe Affiliated TCM Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Dong SunNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.ORCID https://orcid.org/0009-0005-7515-1414

Funding

National Natural Science Foundation of China 32200824National Natural Science Foundation of China 82471539Science and Technology Development Plan of Jilin province 20250102276JCScience and Technology Program of Guangzhou 2025A04J3796STI2030-Major Project 2022ZD0214300
6 · The paper itself

Abstract

Depression, a common neuropsychiatric disorder, profoundly disrupts individuals' daily lives. Although the pathogenesis of depression is intensively investigated for decades, its underlying mechanisms remain elusive. Here, dysfunctional adenylyl cyclase 8 (Adcy8) is identified as a critical risk factor for the development of depression. Adcy8 expression is selectively decreased in the hippocampus, but not in the cortex, thalamus, and hypothalamus, of mice exposed to chronic stress. Adcy8 conditional knockout (CKO) in excitatory neurons, particularly dorsal CA1 (dCA1) neurons, resulted in pronounced depressive-like behaviors. Depletion of Adcy8 in dCA1 neurons reduces neuronal excitability and glutamatergic neurotransmission. Further mechanistic studies reveal a remarkable inhibition of the mitogen-activated protein kinase (MAPK) signaling pathway by Adcy8 CKO, which downregulates parathyroid hormone 2 receptor (PTH2R) level in the hippocampus. Knocking down Pth2r with AAV-shRNA duplicates the impairments in neuronal excitability, glutamatergic neurotransmission and depressive-like behaviors. In contrast, overexpression of PTH2R in Adcy8 CKO hippocampus rescues these deficits. Chronic infusion of TIP39, the endogenous ligand for PTH2R, into the hippocampus also alleviates depressive-like behaviors of Adcy8 CKO mice. Taken together, these results uncover critical roles of Adcy8 in suppressing depressive-like behaviors, likely by maintaining the excitability and glutamatergic neurotransmission of dCA1 neurons through TIP39-PTH2R signaling pathway.

Indexed as

Adenylyl CyclasesCA1 Region, HippocampalDepressionNeuronsSynaptic TransmissionAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, KnockoutSignal Transductionadenylyl cyclase 8Adenylyl CyclasesAdcy8, depressionGlutamatergic neurotransmissionneuronal excitabilityPth2r

Identifiers

PMID41387170
PMCPMC12915128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.